Skip to Main Content
(215) 567-3500

Call Us, We Can Help.

J&J PAYING $181M TO SETTLE CLAIMS OVER RISPERDAL MEDICATION ADS

A Johnson & Johnson subsidiary agreed Thursday to pay $181 million to settle dozens of states’ claims that it engaged in illegal off-label marketing of antipsychotic drugs, with New Jersey to receive $5.3 million. Janssen Pharmaceuticals Inc. of Titusville improperly marketed Risperdal, Risperdal Consta, Risperdal M-Tab and Invega, in violation of federal law, according […]

https://www.chrisplacitella.com/2012/09/02/jj-paying-181m-to-settle-claims-over-risperdal-medication-ads/

Contact us for your consultation (215) 567-3500

Site By: